SEC Company Response from BIO BRIDGE SCIENCE INC (CIK 0001309304) — Jul 1, 2005
BIO BRIDGE SCIENCE INC (CIK 0001309304)
Date: July 1, 2005 · CIK: 0001309304 · Accession: 0001144204-05-020584
AI Filing Summary & Sentiment
File numbers found in text: 333-121786
Show Raw Text
CORRESP
1
filename1.htm
Unassociated Document
RICHARDSON
& PATEL LLP
10900
Wilshire Boulevard
Suite
500
Los
Angeles, CA 90024
Telephone
(310) 208-1182
Facsimile
(310) 208-1154
July
1,
2005
VIA
EDGAR
AND OVERNIGHT COURIER
U.S.
Securities and Exchange Commission
Mail
Stop
0408
450
Fifth
Street, N.W.
Washington,
D.C., 20549
Attn:
Jonathan
Gottlieb, Esq.
Mark Webb, Esq.
Re:
Bio-Bridge
Science, Inc.
Amendment
No. 2 to Registration Statement on Form SB-2
Filed
June 30, 2005
File
No. 333-121786
Dear
Messers. Gottlieb and Webb:
In
furtherance of my telephone conversation with Mr. Gottlieb of yesterday
afternoon, please note that Bio-Bridge Science, Inc. (the “Company”) has made
changes in Amendment No. 2 to Registration Statement on Form SB-2 (File
No.
333-121786) (“Registration Statement”) since the previous version that were not
made in response to any particular comment. The main change consisted
of
additional stockholders to the selling stockholder table who purchased
an
aggregate 570,000 shares of common stock at a price per share of $0.50
from the
Company pursuant to Regulation S under the Securities Act of 1933 from
April 22,
2005 through June 23, 2005.
If
you
have any questions or comments regarding the Registration Statement,
please
contact me by telephone at (310) 208-1182, or by facsimile at (310)
208-1154.
Sincerely,
/s/
Dorothy B. Vinski
Dorothy
B. Vinski